Sarayut Lucien Geater
Researcher Next ID · RN-012900
Researcher · Medicine
, Thailand
- Works count
- 149
- Citation count
- 22,607
- H-index
- 36
- i10-index
- 68
Research interests
Publications
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
New England Journal of Medicine · 2020 · 10.1056/nejmoa1917346
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
The Lancet · 2017 · 10.1016/s0140-6736(17)30123-x
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
The Lancet Oncology · 2015 · 10.1016/s1470-2045(14)71173-8
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
The Lancet Oncology · 2014 · 10.1016/s1470-2045(13)70604-1
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.44.2806
Current projects
No projects listed.